发明名称 |
ANGIOGENICALLY EFFECTIVE UNIT DOSE OF FGF AND METHOD OF ADMINISTERING |
摘要 |
The present invention provides a unit dose comprising 0.2 μg/kg to 36 μg/kg of a recombinant FGF or an angiogenically active fragment or mutein thereof. Also provided is a pharmaceutical composition comprising an angiogenically effective dose of an FGF or an angiogenically active fragment or mutein thereof, and a pharmaceutically acceptable carrier. Also provided is a method for treating a human patient for coronary artery disease, comprising administering into at least one coronary vessel of said patient a safe and angiogenically effective dose of a recombinant FGF of any of SEQ ID NOS:1-3, 5, 8-10, or 12-14, or an angiogenically active fragment or mutein thereof. |
申请公布号 |
US2012165245(A1) |
申请公布日期 |
2012.06.28 |
申请号 |
US20100947939 |
申请日期 |
2010.11.17 |
申请人 |
WHITEHOUSE MARTHA J.;KAVANAUGH W. MICHAEL;NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
发明人 |
WHITEHOUSE MARTHA J.;KAVANAUGH W. MICHAEL |
分类号 |
A61K38/18;A61P9/00;A61P9/10;C07K14/50 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|